149 related articles for article (PubMed ID: 8211266)
1. Cost-effectiveness of neonatal screening for Duchenne muscular dystrophy--how does this compare to existing neonatal screening for metabolic disorders?
Rosenberg T; Jacobs HK; Thompson R; Horne JM
Soc Sci Med; 1993 Aug; 37(4):541-7. PubMed ID: 8211266
[TBL] [Abstract][Full Text] [Related]
2. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
[TBL] [Abstract][Full Text] [Related]
3. Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy.
Hildes E; Jacobs HK; Cameron A; Seshia SS; Booth F; Evans JA; Wrogemann K; Greenberg CR
J Med Genet; 1993 Aug; 30(8):670-4. PubMed ID: 8411054
[TBL] [Abstract][Full Text] [Related]
4. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
[TBL] [Abstract][Full Text] [Related]
5. [Systematic neonatal screening for Duchenne muscular dystrophy].
Dellamonica C; Robert JM; Cotte J; Plauchu H; Dorche C
Nouv Presse Med; 1979 Apr; 8(18):1491-3. PubMed ID: 471723
[TBL] [Abstract][Full Text] [Related]
6. Congenital hydrocephalus secondary to Walker-Warburg syndrome identified on the Manitoba Neonatal Screening Programme for Duchenne muscular dystrophy.
Greenberg CR; Jacobs HK; Nylen TE; Gibb M; Chodirker BN; Moffatt M; Lacson A; Halliday W; Bernier F; el-Husseini A
J Med Genet; 1992 Aug; 29(8):583-5. PubMed ID: 1518026
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of inborn errors of metabolism: necessity or luxury?].
Stöckler S
Wien Klin Wochenschr; 1992; 104(16):493-6. PubMed ID: 1413806
[No Abstract] [Full Text] [Related]
8. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening.
Hauser E; Toifl K; Mad A; Bittner R
Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369
[TBL] [Abstract][Full Text] [Related]
9. Duchenne muscular dystrophy: systematic neonatal screening and earlier detection of carriers.
Plauchu H; Dellamonica C; Cotte J; Robert JM
J Genet Hum; 1980 Dec; 28(4):65-82. PubMed ID: 7205199
[TBL] [Abstract][Full Text] [Related]
10. [Newborn screening for Duchenne muscular dystrophy (author's transl)].
Grimm T
Monatsschr Kinderheilkd; 1981 Jul; 129(7):414-7. PubMed ID: 6115310
[TBL] [Abstract][Full Text] [Related]
11. Duchenne muscular dystrophy: issues in expanding newborn screening.
Kemper AR; Wake MA
Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
[TBL] [Abstract][Full Text] [Related]
12. Health economic analysis of the neonatal screening program in Japan.
Hisashige A
Int J Technol Assess Health Care; 1994; 10(3):382-91. PubMed ID: 8071001
[TBL] [Abstract][Full Text] [Related]
13. Gene studies in newborn males with Duchenne muscular dystrophy detected by neonatal screening.
Greenberg CR; Rohringer M; Jacobs HK; Averill N; Nylen E; van Ommen GJ; Wrogemann K
Lancet; 1988 Aug; 2(8608):425-7. PubMed ID: 2900355
[TBL] [Abstract][Full Text] [Related]
14. Expanded newborn screening for genetic and metabolic disorders: modeling costs and outcomes.
Hubbard HB
Nurs Econ; 2007; 25(6):345-52. PubMed ID: 18240836
[TBL] [Abstract][Full Text] [Related]
15. Newborn screening for inborn errors of metabolism: a systematic review.
Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
[TBL] [Abstract][Full Text] [Related]
16. Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus.
Drousiotou A; Ioannou P; Georgiou T; Mavrikiou E; Christopoulos G; Kyriakides T; Voyasianos M; Argyriou A; Middleton L
Genet Test; 1998; 2(1):55-60. PubMed ID: 10464597
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
Cipriano LE; Rupar CA; Zaric GS
Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
[TBL] [Abstract][Full Text] [Related]
18. [25 years Austrian screening program for inborn errors of metabolism at the Vienna University].
Widhalm K
Wien Klin Wochenschr; 1992; 104(16):510-3. PubMed ID: 1413809
[TBL] [Abstract][Full Text] [Related]
19. Twenty-year follow-up of newborn screening for patients with muscular dystrophy.
Chung J; Smith AL; Hughes SC; Niizawa G; Abdel-Hamid HZ; Naylor EW; Hughes T; Clemens PR
Muscle Nerve; 2016 Apr; 53(4):570-8. PubMed ID: 26260293
[TBL] [Abstract][Full Text] [Related]
20. Duchenne muscular dystrophy: neonatal screening and prenatal diagnosis.
Plauchu H; Dorche C; Cordier MP; Guibaud P; Robert JM
Lancet; 1989 Mar; 1(8639):669. PubMed ID: 2564481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
